Quoin Pharmaceuticals, Ltd.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

QNRX

organization

SIC: 2834

SEC Insider

$810K

68 transactions

Summary

Quoin Pharmaceuticals, Ltd. (QNRX) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $810KSales: $216.819 insiders

Date	Insider	Type	Value
2025-10-14	LANGER DENNIS	Buy	$129K
2026-02-04	Leong Natalie Ee Mun	A	$0
2026-02-04	SEMBER MICHAEL T	A	$0
2026-02-04	LANGER DENNIS	A	$0
2026-02-04	Carter Denise P.(Chief Operating Officer)	A	$0
2026-02-04	Myers Michael(Chief Executive Officer)	A	$0
2026-02-04	Culverwell Anthony James	A	$0
2026-02-04	Cooper Joseph Patrick	A	$0
2026-02-04	Lawlor Sally Bridget(Chief Financial Officer)	A	$0
2025-12-01	Lawlor Sally Bridget(Chief Financial Officer)	A	$0
2025-10-14	LANGER DENNIS	Buy	—
2025-10-14	LANGER DENNIS	Buy	—
2025-10-14	LANGER DENNIS	Buy	—
2025-10-14	LANGER DENNIS	Buy	—
2025-08-21	LANGER DENNIS	A	$0
2025-08-21	Culverwell Anthony James	A	$0
2025-08-21	Leong Natalie Ee Mun	A	$0
2025-05-29	SEMBER MICHAEL T	A	$0
2025-05-29	Cooper Joseph Patrick	A	$0
2025-05-29	LANGER DENNIS	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Quoin Pharmaceuticals, Ltd. — Contributions, Lobbying & Contracts | Poliscope